Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
38.31
+0.19 (0.50%)
At close: Oct 8, 2025, 4:00 PM EDT
38.10
-0.21 (-0.55%)
After-hours: Oct 8, 2025, 6:06 PM EDT
KNSA Market Cap
KNSA has a market cap or net worth of $2.84 billion as of October 8, 2025. Its market cap has increased by 55.42% in one year.
Market Cap
2.84B
Enterprise Value
2.54B
1-Year Change
55.42%
Ranking
Category
Stock Price
$38.31
Market Cap Chart
Since May 24, 2018, KNSA's market cap has increased from $943.14M to $2.84B, an increase of 201.02%. That is a compound annual growth rate of 16.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 2.82B | 97.81% |
| Dec 31, 2024 | 1.43B | 15.76% |
| Dec 29, 2023 | 1.23B | 18.45% |
| Dec 30, 2022 | 1.04B | 28.46% |
| Dec 31, 2021 | 810.82M | -32.59% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |